Nomura Holdings
TGTX icon

Nomura Holdings’s TG Therapeutics TGTX Stock Holding History

Nomura Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,520
Closed -$647K – 2022
2024
Q1 		$647K Buy
+42,520
New +$677K ﹤0.01% 1208
2020
Q3 		– Sell
-10,900
Closed -$212K – 1435
2020
Q2 		$212K Buy
+10,900
New +$176K ﹤0.01% 992

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nomura Holdings's TGTX Position: Q2 2024 in Review

Nomura Holdings sold out of TG Therapeutics (TGTX) in Q2 2024, closing a stake of 42,520 shares — an estimated $647K sold.

Nomura Holdings first reported a position in TGTX in Q2 2020 and held it in 2 quarters. The position peaked at $647K in Q1 2024. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

  • Nomura Holdings reported no remaining TG Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Nomura Holdings sold 42,520 TG Therapeutics shares in Q2 2024, an estimated $647K.
  • Nomura Holdings first reported a position in TG Therapeutics in Q2 2020 and held it in 2 quarters.
  • Nomura Holdings's TG Therapeutics position peaked at $647K in Q1 2024.
  • 259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.